Paper17512799
A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome.
Rosenberg R and 3 others. Sleep Med, 2007. Cited by 71 papers, by iCite.
Cite this record
ConductScience Library. A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome. Papers, record 17512799. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17512799
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypnotics and Sedatives | Major topic |
| Piperazines | Major topic |
| Sleep Apnea, Obstructive | Major topic |
| Adult | |
| Azabicyclo Compounds | |
| Confidence Intervals | |
| Continuous Positive Airway Pressure | |
| Cross-Over Studies | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Pilot Projects | |
| Polysomnography | |
| Severity of Illness Index | |
| Treatment Outcome |
Source PubMed
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42200975 | Obstructive Sleep Apneas and Cardiovascular Diseases. | Clocks Sleep | 2026 | https://conductscience.org/library/papers/42200975 | PubMed |
| 41665171 | Comparative effects of hypnotic agents on sleep architecture and respiratory outcomes in obstructive sleep apnea: A systematic review and network meta-analysis. | Psychiatry Clin Neurosci | 2026 | https://conductscience.org/library/papers/41665171 | PubMed |
| 41426461 | Enhanced expiratory rebreathing space for high loop gain sleep apnea treatment. | Front Sleep | 2023 | https://conductscience.org/library/papers/41426461 | PubMed |
| 39455186 | Sleep Deficiency in Obstructive Sleep Apnea. | Sleep Med Clin | 2024 | https://conductscience.org/library/papers/39455186 | PubMed |
| 39042859 | Hypnotics on Obstructive Sleep Apnea Severity and Endotypes: A Systematic Review and Meta-Analysis. | Am J Respir Crit Care Med | 2024 | https://conductscience.org/library/papers/39042859 | PubMed |
| 38341903 | Pharmacological treatment for obstructive sleep apnea: A systematic review and meta-analysis. | Clinics (Sao Paulo) | 2024 | https://conductscience.org/library/papers/38341903 | PubMed |
| 37230968 | Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37230968 | PubMed |
| 35769417 | Current and novel treatment options for obstructive sleep apnoea. | ERJ Open Res | 2022 | https://conductscience.org/library/papers/35769417 | PubMed |
| 35668288 | Insomnia and Upper Airway Stimulation Therapy Benefit and Adherence: A Case Series. | J Clin Psychol Med Settings | 2023 | https://conductscience.org/library/papers/35668288 | PubMed |
| 35659030 | Sleep Deficiency in Obstructive Sleep Apnea. | Clin Chest Med | 2022 | https://conductscience.org/library/papers/35659030 | PubMed |
| 31766589 | The Role of Animal Models in Developing Pharmacotherapy for Obstructive Sleep Apnea. | J Clin Med | 2019 | https://conductscience.org/library/papers/31766589 | PubMed |
| 31684047 | Targeting Endotypic Traits with Medications for the Pharmacological Treatment of Obstructive Sleep Apnea. A Review of the Current Literature. | J Clin Med | 2019 | https://conductscience.org/library/papers/31684047 | PubMed |
| 31047953 | Apneas of Heart Failure and Phenotype-Guided Treatments: Part One: OSA. | Chest | 2020 | https://conductscience.org/library/papers/31047953 | PubMed |
| 30745935 | The effect of nonbenzodiazepines sedative hypnotics on apnea-hypopnea index: A meta-analysis. | Ann Thorac Med | 2019 | https://conductscience.org/library/papers/30745935 | PubMed |
| 30303519 | Eszopiclone for insomnia. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/30303519 | PubMed |
| 30237498 | Continuous positive airway pressure therapy for obstructive sleep apnoea and psychotropic drug use: a retrospective observational matched-cohort study. | Sci Rep | 2018 | https://conductscience.org/library/papers/30237498 | PubMed |
| 28790874 | Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients. | Nat Sci Sleep | 2017 | https://conductscience.org/library/papers/28790874 | PubMed |
| 27735059 | Impact of concomitant medications on obstructive sleep apnoea. | Br J Clin Pharmacol | 2017 | https://conductscience.org/library/papers/27735059 | PubMed |
| 27166233 | Effects of Zolpidem CR on Sleep and Nocturnal Ventilation in Patients with Heart Failure. | Sleep | 2016 | https://conductscience.org/library/papers/27166233 | PubMed |
| 26715227 | Zopiclone Increases the Arousal Threshold without Impairing Genioglossus Activity in Obstructive Sleep Apnea. | Sleep | 2016 | https://conductscience.org/library/papers/26715227 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17512799
GET https://conductscience.org/api/papers/v1/17512799/cited_by?page=2